7 alpha-hydroxy-4-cholesten-3-one has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuers, U; Chazouillères, O; DePaoli, AM; Drenth, JP; Harrison, SA; Hirschfield, GM; Jaros, MJ; Karsdal, MA; Kim, KH; Landis, CS; Leeming, DJ; Ling, L; Mayo, MJ; Muir, AJ; Rossi, SJ; Somaratne, RM; Thorburn, D; Trotter, JF | 1 |
| Abei, M; Honda, A; Matsuzaki, Y; Osuga, T; Shoda, J; Tanaka, N; Yoshida, T | 1 |
1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
Topics: Alkaline Phosphatase; Bile Acids and Salts; Biomarkers; Biopsy; Cholangiography; Cholangitis, Sclerosing; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Double-Blind Method; Drug Monitoring; Fibroblast Growth Factors; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Treatment Outcome | 2019 |
1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Cirrhosis, Liver
| Article | Year |
|---|---|
Plasma levels of mevalonate and 7alpha-hydroxy-4-cholesten-3-one in chronic liver disease.
Topics: Bile Acids and Salts; Biomarkers; Biopsy, Needle; Cholestenones; Cholesterol; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Male; Mevalonic Acid; Middle Aged; Severity of Illness Index | 1999 |